Tania Crombet Ramos is a medical doctor, having graduated from the Superior Institute of Medical Sciences of Havana (1993), specialising in immunology. She obtained her PhD in 2004.

Since 2004, she is Clinical Research Director of the Centre of Molecular Immunology of Havana, Cuba, and senior faculty of the Superior Institute of Medical Sciences of Havana. As well as being an elected member of the Cuban Academy of Sciences, she is also a member of the Board of Directors of the Innovative Immunotherapy Alliance, a joint venture between the USA and Cuba for immunotherapy; a member of the Cuban and Latin-American Societies of immunology; member of the Cuban and American Society of Oncology; and member of the Cuban National Group of Oncology.

Crombet’s main area of expertise consists on cancer immunotherapy (active and passive) and her work has contributed to the registration in Cuba and abroad of a cancer vaccine and a monoclonal antibody for several epithelial tumors. She has published more than 70 papers and presented her work at more than 200 international congresses. In addition, she has received the Annual Award of the Cuban Academy of Sciences six times, as well as the Young Scientist Award in Biology of The World Academy of Sciences (TWAS) and, in 2008, the Special Award of the Cuban Society of Immunology for her contributions to immunology.

Tania Crombet Ramos is a member of the IAP COVID-19 Expert group.